NMR backbone assignment of the human HSP90 N-terminal domain

human heat shock protein 90 N-terminal domain

NMR backbone assignment of the N-terminal domain of human HSP90.

Human Hsp90 In Complex With 17-desmethoxy-17-n,n- Dimethylaminoethylamino-geldanamycin

Human Hsp90-Alpha With 9-Butyl-8-(3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine

Human Hsp90-alpha With 9-butyl-8-(4-methoxy-benzyl)-9h-purin-6-ylamine

Human Hsp90-Alpha With 9-Butyl-8-(3-Trimethoxy-Benzyl)-9h-Purin-6ylamine

Human Hsp90-Alpha With 8-Benzo[1,3]dioxol-,5-Ylmethyl-9-Butyl-9h-Purin-6-Ylamine

Human Hsp90-Alpha With 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine

Human Hsp90-Alpha With 9-Butyl-8- (2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine

Human Hsp90-Alpha With 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl) -9-Pent-4-Ylnyl-9h-Purin-6-Ylamine

Human Hsp90-Alpha With 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl) -2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine

Human Hsp90-Alpha With 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine

Human Hsp90-Alpha With 9-Butyl-8- (2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine

Human Hsp90-Alpha With 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9- Pent-9h-Purin-6-Ylamine

Human Hsp90-Alpha With 8-Benzo[1,3]dioxol-,5-Ylmethyl-9-But Yl-2-Fluoro-9h-Purin-6-Ylamine

Structure-Activity Relationships In Purine-Based Inhibitor Binding To Hsp90 Isoforms

Crystal Structures Of Human Hsp90alpha Complexed With Dihydroxyphenylpyrazoles

Crystal Structure Of Human Hsp90alpha Complexed With Dihydroxyphenylpyrazoles

Human Hsp90 Geldanamycin-Binding Domain, "closed" Conformation

Human Hsp90 Geldanamycin-Binding Domain, "open" Conformation

Geldanamycin Bound To The Hsp90 Geldanamycin-Binding Domain

Novel, Potent Small Molecule Inhibitors Of The Molecular Chaperone Hsp90 Discovered Through Structure-Based Design

3-(5-Chloro-2,4-Dihydroxyphenyl)-Pyrazole-4-Carboxamides As Inhibitors Of The Hsp90 Molecular Chaperone

Structure-Based Discovery Of A New Class Of Hsp90 Inhibitors

Human Hsp90 With 4-Chloro-6-(4-Piperazin-1-Yl-1h-Pyrazol-3- Yl)-Benzene-1,2-Diol

Human Hsp90 With 5-(5-Chloro-2,4-Dihydroxy-Phenyl)-4- Piperazin-1-Yl-2h-Pyrazole-3-Carboxylic Acid Ethylamide

Human Hsp90 With 4-Chloro-6-(4-(4-(4-Methanesulphonyl- Benzyl)-Pierazin-1-Yl)-1h-Pyrazol-3-Yl)-Benzene-1,3-Diol

Structure Of Human Hsp90-Alpha Bound To The Potent Water Soluble Inhibitor Pu-H64

Structure Of Human Hsp90-alpha Bound To The Potent Water Soluble Inhibitor Pu-h71

Structure Of Human Hsp90-Alpha Bound To The Potent Water Soluble Inhibitor Pu-Dz8

Hsp90 Alpha Atpase Domain With Bound Small Molecule Fragment

Human Cdc37-Hsp90 Docking Model Based On Nmr

Hsp90 Complexed With A143571 And A516383

Inhibition Of The Hsp90 Molecular Chaperone In Vitro And In Vivo By Novel, Synthetic, Potent Resorcinylic Pyrazole, Isoxazole A

4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents For The Treatment Of Cancer

Orally Active 2-Amino Thienopyrimidine Inhibitors Of The Hsp90 Chaperone

Structure Of Hsp90 With An Inhibitor Bound

Structure Of Hsp90 With Small Molecule Inhibitor Bound

Structre Of Hsp90 With Small Molecule Inhibitor Bound

Hsp90 Inhibitors And Drugs From Fragment And Virtual Screening

Structural Characterization Of 5-Aryl-4-(5-Substituted-2-4- Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.

Structural Characterization Of 5-Aryl-4-(5-Substituted-2- 4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.

Hsp90 Alpha N-terminal Domain In Complex With An Aminotriazine Fragment Molecule

Hsp90 Alpha N-terminal Domain In Complex With An Inhibitor Ch4675194

Hsp90 Alpha N-terminal Domain In Complex With An Inhibitor Ro1127850

Hsp90 Alpha N-terminal Domain In Complex With An Inhibitor Ro4919127

Hsp90 Alpha N-terminal Domain In Complex With An Inhibitor Ch5015765

Discovery Of Benzisoxazoles As Potent Inhibitors Of Chaperone Hsp90

Crystal Structure Of Benzamide Tetrahydro-4h-Carbazol-4-One Bound To Hsp90

Dihydroxylphenyl Amides As Inhibitors Of The Hsp90 Molecular Chaperone

Structure Of Hsp90 Bound With A Novel Fragment

Structure Of Hsp90 Bound With A Noval Fragment.

Hsp90 N-Terminal Domain In Complex With 1-{4-[(2r)-1-(5- Chloro-2,4-Dihydroxybenzoyl)pyrrolidin-2-Yl]benzyl}-3,3- Difluoropyrro

Human Heat-Shock Protein 90 (Hsp90) In Complex With {4-[3- (2,4-Dihydroxy-5-Isopropyl-Phenyl)-5-Thioxo- 1,5-Dihydro- [1,2,4]tri

Crystal Structure Of Hsp90 With Fragment 37-D04

Crystal Structure Of Hsp90 With Fragment 42-C03

Crystal Structure Of Hsp90 With Fragments 37-D04 And 42-C03

Crystal Structure Of Hsp90 With Fragment Z064

Hsp90 N-Terminal Domain With Pochoxime A

Hsp90 N-Terminal Domain With Pochoxime B

Hsp90 N-Terminal Domain In Complex With 4-Chloro-6-{[(2r)-2- (2-Methylphenyl)pyrrolidin-1-Yl]carbonyl}benzene-1,3-Diol

Hsp90 N-Terminal Domain In Complex With (1r)-2-(5-Chloro-2, 4-Dihydroxybenzoyl)-N-Ethylisoindoline-1-Carboxamide

Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2h- Isoindol-2-Ylcarbonyl)benzene-1,3-Diol

Crystal Structure Of Benzamide Snx-1321 Bound To Hsp90

Structure Of The Human Hsp90-alpha N-domain Bound To The Hsp90 Inhibitor Pu-h54

Crystal Structure Of Hsp90 With N-Aryl-Benzimidazolone I

Crystal Structure Of Hsp90 With Ver-49009

Crystal Structure Of Hsp90 With N-Aryl-Benzimidazolone Ii

Hsp90a N-Terminal Domain In Complex With Biib021

Design And Sar Of Macrocyclic Hsp90 Inhibitors With Increased Metabolic Stability And Potent Cell-Proliferation Activity

Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90

Macrocyclic Lactams As Potent Hsp90 Inhibitors With Excellent Tumor Exposure And Extended Biomarker Activity.

Discovery Of A Macrocyclic O-Aminobenzamide Hsp90 Inhibitor With Heterocyclic Tether That Shows Extended Biomarker Activity And

Discovery Of A Stable Macrocyclic O-Aminobenzamide Hsp90 Inhibitor Capable Of Significantly Decreasing Tumor Volume In A Mouse

Co-Crystal Structure Of The Hsp90 Atp Binding Domain In Complex With 4-(2,4-Dichloro-5-Methoxyphenyl)-6-Methylpyrimidin-2-Amine

Co-Crystal Structure Of The Hsp90 Atp Binding Domain In Complex With 4-(2,4-Dichloro-5-Methoxyphenyl)-2-Methyl-7h-Pyrrolo[2,3-

Co-crystal Structure Of The Hsp90 Atp Binding Domain In Complex With 4-(2,4-dichloro-5-methoxyphenyl)-2,6-dimethyl-7h-pyrrolo[2

Structure Insights Into Mechanisms Of Atp Hydrolysis And The Activation Of Human Hsp90

Crystal Structure Of The N-Terminal Domain Of An Hsp90 In The Presence Of An The Inhibitor Ganetespib

Hsp90 Alpha N-Terminal Domain In Complex With A Macrocyclic Inhibitor

Hsp90 Alpha N-Terminal Domain In Complex With A Macrocyclic Inhibitor, Ch5164840

Hsp90 Alpha N-terminal Domain In Complex With A Tricyclic Inhibitor

Complex Of Hsp90 Atpase Domain With Tropane Derived Inhibitors

Structure Of Hsp90 With Nms-e973 Inhibitor Bound

Human Hsp90 Alpha N-terminal Domain In Complex With An Aminotriazoloquinazoline Inhibitor

Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor 3-(4- Hydroxy-Phenyl)-1h-Indazol-6-Ol

Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor 3- Cyclohexyl-2-(6-Hydroxy-1h-Indazol-3-Yl)-Propionitrile

Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor 6-Hydroxy- 3-(3-Methyl-Benzyl)-1h-Indazole-5-Carboxylic Acid Benzyl-

Hsp90-Alpha Atpase Domain In Complex With (4-Hydroxyphenyl)morpholin- 4-Yl Methanone

Hsp90-Alpha Atpase Domain In Complex With 2-Amino-4-Ethylthio-6- Methyl-1,3,5-Triazine

Human Hsp90-Alpha Atpase Domain Bound To Radicicol

Targetting Conserved Water Molecules: Design Of 4-Aryl-5-Cyanopyrrolo [2,3-D] Pyrimidine Hsp90 Inhibitors Using Fragment-Based

Targeting Conserved Water Molecules: Design Of 4-Aryl-5- Cyanopyrrolo[2,3-D]pyrimidine Hsp90 Inhibitors Using Fragment-Based Sc

Crystal Structure Of The Human Hsp90-alpha N-domain Bound To The Hsp90 Inhibitor Fj1

Synthesis Of Benzoquinone-ansamycin-inspired Macrocyclic Lactams From Shikimic Acid

Crystal Structure Of Human Hsp90 With Rl1

Crystal Structure Of Human Hsp90 With Rl3

Crystal Structure Of Human Hsp90 With X29

Crystal Structure Of Human Hsp90 With S36

Crystal Structure Of Human Hsp90 With S46

Crystal Structure Of The Human Hsp90-alpha N-domain Bound To The Hsp90 Inhibitor Fj2

Crystal Structure Of The Human Hsp90-alpha N-domain Bound To The Hsp90 Inhibitor Fj3

Crystal Structure Of The Human Hsp90-alpha N-domain Bound To The Hsp90 Inhibitor Fj4

Crystal Structure Of The Human Hsp90-alpha N-domain Bound To The Hsp90 Inhibitor Fj5

Crystal Structure Of The Human Hsp90-alpha N-domain Bound To The Hsp90 Inhibitor Fj6

Correlation Between Chemotype-dependent Binding Conformations Of Hsp90 Alpha/beta And Isoform Selectivity

Identification Of Novel Hsp90/isoform Selective Inhibitors Using Structure-based Drug Design. Demonstration Of Potential Utilit

Identification Of Novel Hsp90 / Isoform Selective Inhibitors Using Structure-based Drug Design. Demonstration Of Potential Util

Crystal Structure Of Human Hsp90 With Jr9

Crystal Structure Of Hsp90-alpha N-domain Bound To The Inhibitor Nvp- Hsp990

heat shock protein 90 alpha [Equus caballus]

90-kDa heat shock protein alpha [Bos taurus]

heat shock protein 86 [Rattus norvegicus]

heat shock protein 86, partial [Homo sapiens]

heat shock protein 90A [Cricetulus griseus]

heat-shock protein hsp86, partial [Mus musculus]

heat shock protein HSP 90-alpha [Bos taurus]

heat shock protein HSP 90-alpha isoform 1 [Homo sapiens]

heat shock protein HSP 90-alpha [Pan troglodytes]

heat shock protein HSP 90-alpha [Equus caballus]

heat shock protein 90kDa alpha (cytosolic), class A member 1 [Macaca mulatta]

RecName: Full=Heat shock protein HSP 90-alpha [Pan troglodytes]

RecName: Full=Heat shock protein HSP 90-alpha [Sus scrofa]

RecName: Full=Heat shock protein HSP 90-alpha; AltName: Full=Heat shock 86 kDa; Short=HSP 86; Short=HSP86; AltName: Full=Lipopo

RecName: Full=Heat shock protein HSP 90-alpha; AltName: Full=Heat shock 86 kDa; Short=HSP 86; Short=HSP86; AltName: Full=Tumor-

RecName: Full=Heat shock protein HSP 90-alpha [Oryctolagus cuniculus]

TPA: heat shock protein HSP 90-alpha [Bos taurus]